Private equity firms are circling Bayer’s €10bn plastics business, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said yesterday.

German pharmaceutical giant Bayer has posted a 2003 operating loss of €1.203bn - worse than analyst expectations - but the group said it is aiming for an earnings growth for 2004.